These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 16622085)
1. Incidence of ocular morbidity among multibacillary leprosy patients during a 2 year course of multidrug therapy. Daniel E; Ffytche TJ; Sundar Rao PS; Kempen JH; Diener-West M; Courtright P Br J Ophthalmol; 2006 May; 90(5):568-73. PubMed ID: 16622085 [TBL] [Abstract][Full Text] [Related]
2. Incidence of ocular complications in patients with multibacillary leprosy after completion of a 2 year course of multidrug therapy. Daniel E; Ffytche TJ; Kempen JH; Rao PS; Diener-West M; Courtright P Br J Ophthalmol; 2006 Aug; 90(8):949-54. PubMed ID: 16707521 [TBL] [Abstract][Full Text] [Related]
3. Iris atrophy in patients with newly diagnosed multibacillary leprosy: at diagnosis, during and after completion of multidrug treatment. Daniel E; Sundar Rao PS; Ffytche TJ; Chacko S; Prasanth HR; Courtright P Br J Ophthalmol; 2007 Aug; 91(8):1019-22. PubMed ID: 17108015 [TBL] [Abstract][Full Text] [Related]
4. Lagophthalmos in a multibacillary population under multidrug therapy in the People's Republic of China. Courtright P; Lewallen S; Li HY; Hu LF; Yang JW Lepr Rev; 1995 Sep; 66(3):214-9. PubMed ID: 7500816 [TBL] [Abstract][Full Text] [Related]
5. Ocular hypotension and hypotony in multibacillary leprosy patients; at diagnosis, during and after completion of multidrug therapy. Daniel E; Rao PS; Ffytche TJ; Courtright P Indian J Lepr; 2010; 82(4):181-8. PubMed ID: 21434594 [TBL] [Abstract][Full Text] [Related]
6. Eye disease in multibacillary leprosy patients at the time of their leprosy diagnosis: findings from the Longitudinal Study of Ocular Leprosy (LOSOL) in India, the Philippines and Ethiopia. Courtright P; Daniel E; Sundarrao ; Ravanes J; Mengistu F; Belachew M; Celloria RV; Ffytche T Lepr Rev; 2002 Sep; 73(3):225-38. PubMed ID: 12449887 [TBL] [Abstract][Full Text] [Related]
7. Longitudinal ocular survey of 202 Filipino patients with multi-bacillary (MB) leprosy treated with 2 year WHO-multiple drug therapy. Ravanes JM; Cellona RV; Balagon M; Abalos RM; Walsh GP; Walsh DS Southeast Asian J Trop Med Public Health; 2011 Mar; 42(2):323-30. PubMed ID: 21710853 [TBL] [Abstract][Full Text] [Related]
8. Multidrug therapy and eye disease in leprosy: a cross-sectional study in the People's Republic of China. Courtright P; Hu LF; Li HY; Lewallen S Int J Epidemiol; 1994 Aug; 23(4):835-42. PubMed ID: 8002199 [TBL] [Abstract][Full Text] [Related]
9. Ocular findings in leprosy patients in Nepal in the era of multidrug therapy. Nepal BP; Shrestha UD Am J Ophthalmol; 2004 May; 137(5):888-92. PubMed ID: 15126154 [TBL] [Abstract][Full Text] [Related]
10. Ocular manifestation in treated multibacillary Hansen's disease. Parikh R; Thomas S; Muliyil J; Parikh S; Thomas R Ophthalmology; 2009 Nov; 116(11):2051-7.e1. PubMed ID: 19766316 [TBL] [Abstract][Full Text] [Related]
11. Comparative study of uniform-MDT and WHO MDT in Pauci and Multi bacillary leprosy patients over 24 months of observation. Rao PN; Suneetha S; Pratap DV Lepr Rev; 2009 Jun; 80(2):143-55. PubMed ID: 19743618 [TBL] [Abstract][Full Text] [Related]
12. Is leprosy blindness avoidable? The effect of disease type, duration, and treatment on eye damage from leprosy in Uganda. Waddell KM; Saunderson PR Br J Ophthalmol; 1995 Mar; 79(3):250-6. PubMed ID: 7703204 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity. Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255 [TBL] [Abstract][Full Text] [Related]
14. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients. Kaur I; Dogra S; Kumar B; Radotra BD Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965 [TBL] [Abstract][Full Text] [Related]
15. Field evaluation of WHO-MDT of fixed duration, at ALERT, Ethiopia: the AMFES project--II. Reaction and neuritis during and after MDT in PB and MB leprosy patients. de Rijk AJ; Gabre S; Byass P; Berhanu T Lepr Rev; 1994 Dec; 65(4):320-32. PubMed ID: 7861918 [TBL] [Abstract][Full Text] [Related]
16. Immunochemotherapy with interferon-gamma and multidrug therapy for multibacillary leprosy. Barral-Netto M; Santos S; Santos I; von Sohsten R; Bittencourt AL; Carvalho EM; Barral A; Waters M Acta Trop; 1999 Mar; 72(2):185-201. PubMed ID: 10206118 [TBL] [Abstract][Full Text] [Related]
17. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients. Penna GO; Bührer-Sékula S; Kerr LRS; Stefani MMA; Rodrigues LC; de Araújo MG; Ramos AMC; de Andrade ARC; Costa MB; Rosa PS; Gonçalves HS; Cruz R; Barreto ML; Pontes MAA; Penna MLF PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005725. PubMed ID: 28704363 [TBL] [Abstract][Full Text] [Related]
18. Nerve function impairment in leprosy at diagnosis and at completion of MDT: a retrospective cohort study of 786 patients in Bangladesh. Richardus JH; Finlay KM; Croft RP; Smith WC Lepr Rev; 1996 Dec; 67(4):297-305. PubMed ID: 9033200 [TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and outcome in multibacillary (MB) leprosy patients treated with 12 months WHO MDT-MBR: a retrospective analysis of 730 patients from a leprosy clinic at a tertiary care hospital of Northern India. Dogra S; Kumaran MS; Narang T; Radotra BD; Kumar B Lepr Rev; 2013 Mar; 84(1):65-75. PubMed ID: 23741883 [TBL] [Abstract][Full Text] [Related]
20. Disabilities in multibacillary leprosy patients: before, during and after multidrug therapy. Sharma P; Kar HK; Beena KR; Kaur H; Narayan R Indian J Lepr; 1996; 68(2):127-36. PubMed ID: 8835580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]